Project Grant R01DA062638
Award Date 8/15/25
Completion Date 4/30/30
Dollars Obligated $777K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
- This Project Grant award of $2,332,500.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to transform systems of care in Washington state prisons to better address HIV, HIV risk, and substance use disorders. The key products and services to be delivered include: Building the foundation for a "prison learning health system" to improve the quality, efficiency, and reach of HIV treatment, HIV prevention, and...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to optimize opioid use disorder (OUD) treatment in prisons. The key products and services to be delivered include: Validating a 2-item OUD screening tool and an 11-item diagnostic DSM-5 OUD symptom checklist adapted for use in prisons. This will involve validating these tools against...
- The University of Washington was awarded a $1,024,374 Cooperative Agreement by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a large, multi-site pragmatic 3-arm cluster randomized control trial. The project, titled "Equitable Primary Care for Pain Care (EQUIP PC)", aims to adapt an Integrated Behavioral Health in Primary Care (IBH-PC) toolkit to improve equitable access to chronic pain...
- This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,746,930.00 to New York University School of Medicine to conduct a stepped wedge randomized controlled trial (RCT). The study aims to evaluate the impact of a technical assistance (TA) intervention designed to support permanent supportive housing (PSH) agencies in implementing evidence-based practices to reduce tenant overdose and...
- The University of California, San Diego (UCSD) was awarded a $4,874,620 Cooperative Agreement from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support a binational cohort study to prospectively examine the intersection of substance use, HIV, and associated comorbidities among people who inject drugs in the San Diego region. Key objectives include characterizing trends and predictors of established and emerging...
- This $2,267,819 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Abuse and Addiction Research Programs) will fund research by the University of Washington to characterize extracellular vesicle (EV) profiles in healthy pregnancies and those complicated by opioid use disorder. The goal is to identify biomarkers in placental EVs and fetal brain/central nervous system EVs that could predict an infant's risk of developing neonatal opioid withdrawal syndrome (NOWS) and...
- This federal Project Grant award, with ID K01DA060359, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $195,728 grant will fund a 5-year study to assess the acceptability and feasibility of using pharmacogenomic (PGX) testing to guide opioid use disorder (OUD) treatment. The key objectives of this project are to: 1) identify barriers and facilitators impacting the acceptability and feasibility of a PGX testing...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $823,882 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Oregon Health & Science University (OHSU) on July 15, 2025. The TEAM-UP: Tobacco Treatment Navigators Uniting with Primary Care project aims to implement and compare two outreach strategies, a person-based Outreach Navigator (ON) and a technology-based Interactive Patient Portal (IPP), to improve...
- The University of California, San Diego (UCSD) was awarded a $2,078,061 Cooperative Agreement by the National Institute on Drug Abuse (CFDA 93.279 Drug Use and Addiction Research Programs) to conduct the "Responding to the Increase in Substance Use, HIV, HCV, and Overdose in New England" (RISE-NE) cohort study. This five-year project aims to systematically examine evolving trends in substance use, HIV, hepatitis C, and overdose in New England. The study will recruit a cohort of 1,200...
- The U.S. National Institutes of Health (NIH) awarded a Cooperative Agreement under the Trans-NIH Research Support program (CFDA 93.310) to Wake Forest University Health Sciences (WFUHS) in the amount of $1,098,513 beginning September 1, 2025. The overarching goal of the "CASCADE" (Carolina Addiction Science Coalition for Accelerating Discovery and Engagement) project is to investigate the impacts of drug use patterns and addiction treatment on the HIV prevention and care cascade in the...